64 results
Type of content
Events Remove Events filter
-
List item
Paediatric Committee (PDCO): 23-26 January 2018
European Medicines Agency, London, UK, from 23/01/2018 to 26/01/2018, Last updated: 10/04/201813 2.1.16. Ezetimibe / Rosuvastatin - EMEA-002257-PIP01-17 … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 March 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/03/2021 to 11/03/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/2018 -
List item
European Medicines Agency/European Federation of Pharmaceutical Industries and Associations workshop: Integrating pharmacogenomics early into drug development: pharmacokinetics as a working example
European Medicines Agency, London, UK, 20/12/2008, Last updated: 20/12/2008 -
List item
Paediatric Committee (PDCO): 18-21 April 2017
European Medicines Agency, London, UK, from 18/04/2017 to 21/04/2017, Last updated: 03/07/20148 2.1.6. Ezetimibe / Rosuvastatin (calcium … -
List item
Paediatric Committee (PDCO): 12-15 September 2017
European Medicines Agency, London, UK, from 12/09/2017 to 15/09/2017, Last updated: 03/07/201412 2.1.11. Ezetimibe / Rosuvastatin - EMEA-002202-PIP01-17 … -
List item
Paediatric Committee (PDCO): 16-19 May 2017
European Medicines Agency, London, UK, from 16/05/2017 to 19/05/2017, Last updated: 03/07/201412 2.1.13. Ezetimibe / Rosuvastatin (calcium … 12 2.1.14. Ezetimibe / Rosuvastatin (calcium … -
List item
Paediatric Committee (PDCO): 20-22 July 2016
European Medicines Agency, London, UK, from 20/07/2016 to 22/07/2016, Last updated: 04/08/2016treatment of hypertension; • Ezetimibe / Rosuvastatin (calcium … -
List item
Paediatric Committee (PDCO): 15-18 August 2017
European Medicines Agency, London, UK, from 15/08/2017 to 18/08/2017, Last updated: 03/07/2014 -
List item
Management Board meeting: 16-17 March 2011
European Medicines Agency, London, UK, from 16/03/2011 to 17/03/2011, Last updated: 01/09/2011 -
List item
Paediatric Committee (PDCO): 10-13 October 2017
European Medicines Agency, London, UK, from 10/10/2017 to 13/10/2017, Last updated: 03/07/20149 2.1.9. Ezetimibe / atorvastatin - EMEA-002207-PIP01-17 … -
List item
Paediatric Committee (PDCO): 20-23 February 2018
European Medicines Agency, London, UK, from 20/02/2018 to 23/02/2018, Last updated: 18/07/20149 2.1.6. Rosuvastatin / ezetimibe - EMEA-001344-PIP02-17 … -
List item
Paediatric Committee (PDCO): 12-15 December 2017
European Medicines Agency, London, UK, from 12/12/2017 to 15/12/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 22-24 June 2016
European Medicines Agency, London, UK, from 22/06/2016 to 24/06/2016, Last updated: 04/08/2016 -
List item
Paediatric Committee (PDCO): 16-19 October 2018
European Medicines Agency, London, UK, from 16/10/2018 to 19/10/2018, Last updated: 22/11/201810 2.1.10. Ezetimibe / atorvastatin - EMEA-002410-PIP01-18 … -
List item
Paediatric Committee (PDCO): 24-27 January 2017
European Medicines Agency, London, UK, from 24/01/2017 to 27/01/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 21-24 March 2017
European Medicines Agency, London, UK, from 21/03/2017 to 24/03/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 20-22 May 2015
European Medicines Agency, London, UK, from 20/05/2015 to 22/05/2015, Last updated: 20/05/2015 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 31 August-3 September 2020
Virtual meeting, from 31/08/2020 to 03/09/2020, Last updated: 27/02/2018 -
List item
Paediatric Committee (PDCO): 6-8 June 2012
European Medicines Agency, London, UK, from 06/06/2012 to 08/06/2012, Last updated: 25/08/2011 -
List item
Paediatric Committee (PDCO): 13-16 December 2016
European Medicines Agency, London, UK, from 13/12/2016 to 16/12/2016, Last updated: 30/06/2014 -
List item
Paediatric Committee (PDCO): 7-9 December 2011
European Medicines Agency, London, UK, from 07/12/2011 to 09/12/2011, Last updated: 11/06/2010 Atorvastatin calcium / ezetimibe, from Merck Sharp & Dohme … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 27/09/2021 to 30/09/2021, Last updated: 27/02/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2021 to 22/04/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 February 2010
European Medicines Agency, London, UK, from 15/02/2010 to 18/02/2010, Last updated: 15/02/2010treatment of colesevelam with ezetimibe, with or without a statin …